Invention Grant
- Patent Title: Quick dissolving diphenhydramine oral dosage form
-
Application No.: US14973759Application Date: 2015-12-18
-
Publication No.: US09855227B2Publication Date: 2018-01-02
- Inventor: Richard John Dansereau , Brian Laster , Erin Swigart , Ashraf Traboulsi
- Applicant: The Procter & Gamble Company
- Applicant Address: US OH Cincinnati
- Assignee: The Procter & Gamble Company
- Current Assignee: The Procter & Gamble Company
- Current Assignee Address: US OH Cincinnati
- Agent Amanda Herman; Alxeandra S. Anoff
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/135 ; A61K9/19 ; A61K47/12 ; A61K47/22 ; A61K31/138 ; A61J1/03 ; A61K31/4425

Abstract:
An oral dosage form to deliver diphenhydramine through the sublingual or buccal mucosa. The oral dosage form can contain diphenhydramine, or a pharmaceutically acceptable salt thereof, a permeability enhancer, and a buffering agent. The buffering agent can achieve a pH of about 7.0 to about 8.0. The diphenhydramine can completely dissolve within about 2 minutes.
Public/Granted literature
- US20170172948A1 Quick Dissolving Diphenhydramine Oral Dosage Form Public/Granted day:2017-06-22
Information query